Strides Pharma Science informs about press release

30 May 2022 Evaluate

Strides Pharma Science has informed that it enclosed a Press Release issued by the Company titled: ‘Strides receives USFDA approval for Ibuprofen Oral Suspension’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1564.45 9.15 (0.59%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.